United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
NEW YORK, Jan. 29, 2014 /PRNewswire/ — Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare, a division of UnitedHealth Group (NYSE:UNH), to provide the pathology analysis for these specialty services.
Under the agreement, Therapath will work directly with the United Healthcare physician network to handle and process the pathology specimens at a fraction of the cost of non-participating pathology laboratories. In addition, the transaction will improve the turn-around time of results for both the patients and physicians.
Therapath Neuropathology, founded in 2004, is a College of American Pathology (CAP) accredited laboratory that provides pathology services throughout the United States. It currently serves clients (medical centers and physicians) from every state in the US. Physicians in United Healthcare’s network can submit their specimens directly to Therapath.
“Therapath’s partnership with United Healthcare will provide a (better) high quality, reliable and more convenient experience for United Healthcare physicians and members at a lower cost than traditional non specialized labs,” said Charles (Chip) Hearn, Director of Finance at Therapath. “Our process ensures a simplified, consistent process to submit these specialized biopsy specimens which will benefit both the physicians and UNH members.”
About Therapath Neuropathology:
Therapath LLC, is privately held and offers its specialized neuromuscular pathology services to academic institutions, research organizations, and pharmaceutical companies, for both clinical and pre-clinical investigations of potential therapeutic agents, toxicity, or regeneration studies. Therapath provides complete testing of Muscle Biopsy; Nerve Biopsy; skin biopsy for Small Fiber Neuropathy: Epidermal Nerve Fiber Density (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD); and skin biopsy for neurological disease with Electron Microscopy. Therapath provides consultations for brain, spinal cord tumor biopsy, and resection specimens; non-neoplastic brain and spinal cord biopsy specimens; and brain and spinal cord autopsy specimens, including dementias.
Therapath is headquartered in New York, NY. Visit Therapath online at www.therapath.com
Contact:
Therapath Neuropathology
Geoff Whitehouse, 800-681-4338
gwhitehouse@therapath.com
Related Articles
Epidermal Nerve Fiber Density Test – Biopsy Sites
Becky Tsai2022-09-05T19:02:43-05:00
Therapath has established five standard biopsy sites for Epidermal Nerve Fiber Density (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD). [Read More]
Abstract: Associated Conditions in Small Fiber Neuropathy
Becky Tsai2022-09-05T19:01:46-05:00
De Greef et al. studied 921 patients with confirmed small fiber neuropathy in order to investigate the prevalence of associated conditions in SFN patients. [Read More]
Abstract: Idiopathic Small Fiber Neuropathy in Children
Becky Tsai2022-09-05T17:30:24-05:00
Balushi, Kim, Krause, and Kafie looked at idiopathic small fiber neuropathy findings in children who had small fiber neuropathy confirmed by history, clinical exam, and low intraepidermal nerve fiber density. [Read More]
Abstract: Prediabetes and Small Fiber Neuropathy
Becky Tsai2022-09-05T17:45:25-05:00
Thaisetthawatkul, Fernandes, and Herrmann looked at the connection between prediabetes and small fiber neuropathy. [Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
NEW YORK, Jan. 29, 2014 /PRNewswire/ — Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare, a division of UnitedHealth Group (NYSE:UNH), to provide the pathology analysis for these specialty services.
Under the agreement, Therapath will work directly with the United Healthcare physician network to handle and process the pathology specimens at a fraction of the cost of non-participating pathology laboratories. In addition, the transaction will improve the turn-around time of results for both the patients and physicians.
Therapath Neuropathology, founded in 2004, is a College of American Pathology (CAP) accredited laboratory that provides pathology services throughout the United States. It currently serves clients (medical centers and physicians) from every state in the US. Physicians in United Healthcare’s network can submit their specimens directly to Therapath.
“Therapath’s partnership with United Healthcare will provide a (better) high quality, reliable and more convenient experience for United Healthcare physicians and members at a lower cost than traditional non specialized labs,” said Charles (Chip) Hearn, Director of Finance at Therapath. “Our process ensures a simplified, consistent process to submit these specialized biopsy specimens which will benefit both the physicians and UNH members.”
About Therapath Neuropathology:
Therapath LLC, is privately held and offers its specialized neuromuscular pathology services to academic institutions, research organizations, and pharmaceutical companies, for both clinical and pre-clinical investigations of potential therapeutic agents, toxicity, or regeneration studies. Therapath provides complete testing of Muscle Biopsy; Nerve Biopsy; skin biopsy for Small Fiber Neuropathy: Epidermal Nerve Fiber Density (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD); and skin biopsy for neurological disease with Electron Microscopy. Therapath provides consultations for brain, spinal cord tumor biopsy, and resection specimens; non-neoplastic brain and spinal cord biopsy specimens; and brain and spinal cord autopsy specimens, including dementias.
Therapath is headquartered in New York, NY. Visit Therapath online at www.therapath.com
Contact:
Therapath Neuropathology
Geoff Whitehouse, 800-681-4338
gwhitehouse@therapath.com
Related Articles
Epidermal Nerve Fiber Density Test – Biopsy Sites
Becky Tsai2022-09-05T19:02:43-05:00
Therapath has established five standard biopsy sites for Epidermal Nerve Fiber Density (ENFD) and Sweat Gland Nerve Fiber Density (SGNFD). [Read More]
Abstract: Associated Conditions in Small Fiber Neuropathy
Becky Tsai2022-09-05T19:01:46-05:00
De Greef et al. studied 921 patients with confirmed small fiber neuropathy in order to investigate the prevalence of associated conditions in SFN patients. [Read More]
Abstract: Idiopathic Small Fiber Neuropathy in Children
Becky Tsai2022-09-05T17:30:24-05:00
Balushi, Kim, Krause, and Kafie looked at idiopathic small fiber neuropathy findings in children who had small fiber neuropathy confirmed by history, clinical exam, and low intraepidermal nerve fiber density. [Read More]
Abstract: Prediabetes and Small Fiber Neuropathy
Becky Tsai2022-09-05T17:45:25-05:00
Thaisetthawatkul, Fernandes, and Herrmann looked at the connection between prediabetes and small fiber neuropathy. [Read More]
